Thus, the negative association of the circulating levels of adropin with Agatston stages of coronary calcification, which we first detected in the study, opens new perspectives for early screening of individuals who are either angiographically negative or have no clinically significant coronary artery stenosis. The gene discussed is ENHO; the disease is coronary stenosis.